vs
百利高（PRGO）与Vici Properties（VICI）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是Vici Properties的1.1倍（$1.1B vs $1.0B），Vici Properties净利率更高（59.7% vs -127.8%，领先187.5%），Vici Properties同比增速更快（3.8% vs -2.5%），过去两年Vici Properties的营收复合增速更高（3.2% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
Vici Properties是总部位于美国纽约的房地产投资信托（REIT），专注于博彩及娱乐类物业。公司成立于2017年，由凯撒娱乐集团破产重组时分拆而来，目前在美加两国持有54家赌场、酒店、赛马场，4座高尔夫球场及38个保龄球馆。
PRGO vs VICI — 直观对比
营收规模更大
PRGO
是对方的1.1倍
$1.0B
营收增速更快
VICI
高出6.3%
-2.5%
净利率更高
VICI
高出187.5%
-127.8%
两年增速更快
VICI
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.0B |
| 净利润 | $-1.4B | $604.8M |
| 毛利率 | 32.6% | 99.3% |
| 营业利润率 | -116.0% | 60.2% |
| 净利率 | -127.8% | 59.7% |
| 营收同比 | -2.5% | 3.8% |
| 净利润同比 | -3093.9% | -1.6% |
| 每股收益（稀释后） | $-10.23 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOVICI
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.1B | $1.0B | ||
| Q1 25 | $1.0B | $984.2M | ||
| Q4 24 | $1.1B | $976.1M | ||
| Q3 24 | $1.1B | $964.7M | ||
| Q2 24 | $1.1B | $957.0M | ||
| Q1 24 | $1.1B | $951.5M |
净利润PRGOVICI
| Q4 25 | $-1.4B | $604.8M | ||
| Q3 25 | $7.5M | $762.0M | ||
| Q2 25 | $-8.4M | $865.1M | ||
| Q1 25 | $-6.4M | $543.6M | ||
| Q4 24 | $-44.4M | $614.6M | ||
| Q3 24 | $-21.0M | $732.9M | ||
| Q2 24 | $-108.4M | $741.3M | ||
| Q1 24 | $2.0M | $590.0M |
毛利率PRGOVICI
| Q4 25 | 32.6% | 99.3% | ||
| Q3 25 | 36.1% | 99.3% | ||
| Q2 25 | 34.4% | 99.3% | ||
| Q1 25 | 37.6% | 99.4% | ||
| Q4 24 | 33.9% | 99.3% | ||
| Q3 24 | 37.2% | 99.3% | ||
| Q2 24 | 37.0% | 99.3% | ||
| Q1 24 | 33.1% | 99.3% |
营业利润率PRGOVICI
| Q4 25 | -116.0% | 60.2% | ||
| Q3 25 | 7.0% | 77.2% | ||
| Q2 25 | 4.3% | 88.3% | ||
| Q1 25 | 4.5% | 55.9% | ||
| Q4 24 | 10.0% | 64.2% | ||
| Q3 24 | 7.4% | 77.4% | ||
| Q2 24 | -2.5% | 79.0% | ||
| Q1 24 | -5.1% | 63.2% |
净利率PRGOVICI
| Q4 25 | -127.8% | 59.7% | ||
| Q3 25 | 0.7% | 75.6% | ||
| Q2 25 | -0.8% | 86.4% | ||
| Q1 25 | -0.6% | 55.2% | ||
| Q4 24 | -3.9% | 63.0% | ||
| Q3 24 | -1.9% | 76.0% | ||
| Q2 24 | -10.2% | 77.5% | ||
| Q1 24 | 0.2% | 62.0% |
每股收益（稀释后）PRGOVICI
| Q4 25 | $-10.23 | $0.57 | ||
| Q3 25 | $0.05 | $0.71 | ||
| Q2 25 | $-0.06 | $0.82 | ||
| Q1 25 | $-0.05 | $0.51 | ||
| Q4 24 | $-0.32 | $0.58 | ||
| Q3 24 | $-0.15 | $0.70 | ||
| Q2 24 | $-0.79 | $0.71 | ||
| Q1 24 | $0.01 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $608.0M |
| 总债务越低越好 | — | $16.8B |
| 股东权益账面价值 | $2.9B | $27.8B |
| 总资产 | $8.5B | $46.7B |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资PRGOVICI
| Q4 25 | — | $608.0M | ||
| Q3 25 | $432.1M | $507.5M | ||
| Q2 25 | $454.2M | $233.0M | ||
| Q1 25 | $409.9M | $334.3M | ||
| Q4 24 | $558.8M | $524.6M | ||
| Q3 24 | $1.5B | $355.7M | ||
| Q2 24 | $542.8M | $347.2M | ||
| Q1 24 | $658.5M | $514.9M |
总债务PRGOVICI
| Q4 25 | — | $16.8B | ||
| Q3 25 | — | $16.8B | ||
| Q2 25 | — | $16.9B | ||
| Q1 25 | — | $16.8B | ||
| Q4 24 | — | $16.7B | ||
| Q3 24 | — | $16.7B | ||
| Q2 24 | — | $16.7B | ||
| Q1 24 | — | $16.7B |
股东权益PRGOVICI
| Q4 25 | $2.9B | $27.8B | ||
| Q3 25 | $4.4B | $27.7B | ||
| Q2 25 | $4.5B | $27.0B | ||
| Q1 25 | $4.4B | $26.6B | ||
| Q4 24 | $4.3B | $26.5B | ||
| Q3 24 | $4.6B | $26.1B | ||
| Q2 24 | $4.5B | $25.7B | ||
| Q1 24 | $4.7B | $25.4B |
总资产PRGOVICI
| Q4 25 | $8.5B | $46.7B | ||
| Q3 25 | $10.1B | $46.5B | ||
| Q2 25 | $10.1B | $46.1B | ||
| Q1 25 | $9.8B | $45.5B | ||
| Q4 24 | $9.6B | $45.4B | ||
| Q3 24 | $11.2B | $44.9B | ||
| Q2 24 | $10.4B | $44.5B | ||
| Q1 24 | $10.6B | $44.2B |
负债/权益比PRGOVICI
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.66× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $691.9M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | — |
| 自由现金流率自由现金流/营收 | 13.4% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.14× |
| 过去12个月自由现金流最近4个季度 | $145.1M | — |
8季度趋势，按日历期对齐
经营现金流PRGOVICI
| Q4 25 | $175.4M | $691.9M | ||
| Q3 25 | $51.7M | $586.3M | ||
| Q2 25 | $75.9M | $639.9M | ||
| Q1 25 | $-64.5M | $591.9M | ||
| Q4 24 | $312.6M | $644.1M | ||
| Q3 24 | $42.2M | $579.1M | ||
| Q2 24 | $9.5M | $614.6M | ||
| Q1 24 | $-1.4M | $543.7M |
自由现金流PRGOVICI
| Q4 25 | $148.6M | — | ||
| Q3 25 | $29.8M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $274.9M | — | ||
| Q3 24 | $15.1M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-26.5M | — |
自由现金流率PRGOVICI
| Q4 25 | 13.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | -8.6% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | -1.8% | — | ||
| Q1 24 | -2.4% | — |
资本支出强度PRGOVICI
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.3% | — |
现金转化率PRGOVICI
| Q4 25 | — | 1.14× | ||
| Q3 25 | 6.89× | 0.77× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 1.05× | ||
| Q3 24 | — | 0.79× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | -0.70× | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
VICI
| Fixed Rent | $504.3M | 50% |
| Other | $478.4M | 47% |
| Contingent Rent | $30.4M | 3% |
